153 related articles for article (PubMed ID: 15678821)
1. [Cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002].
Raharisolo Vololonantenaina CR; Rabarijaona LP; Soares JL; Rasendramino M; Pécarrère JL; Khun H; Huerre M
Arch Inst Pasteur Madagascar; 2003; 69(1-2):77-81. PubMed ID: 15678821
[TBL] [Abstract][Full Text] [Related]
2. [Management of breast cancers diagnosed at the Pasteur Institute of Madagascar from 1995 to 2001].
Raharisolo Vololonantenaina CR; Rabarijaona LP; Rajemiarimoelisoa C; Rasendramino M; Migliani R
Arch Inst Pasteur Madagascar; 2002; 68(1-2):104-8. PubMed ID: 12643103
[TBL] [Abstract][Full Text] [Related]
3. [Value and limits of cytology in the diagnosis of cervico-vaginal lesions at the Mahajanga University Hospital Center: 465 cases].
Ravolamanana Ralisata L; Randrianjafisamindrakotroka NS; Rakoto EB; Ranaivozanany A
Arch Inst Pasteur Madagascar; 1999; 65(1-2):120-3. PubMed ID: 12478977
[TBL] [Abstract][Full Text] [Related]
4. [A rare cancer: cancers of the small intestine. 25 cases diagnosed at the Institut Pasteur de Madagascar from 1992 to 2001].
Raharisolo Vololonantenaina CR; Dina TJ; Ravalisoa A
Arch Inst Pasteur Madagascar; 2003; 69(1-2):82-6. PubMed ID: 15678822
[TBL] [Abstract][Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
8. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
9. Results of longterm hospital based cytological screening in asymptomatic women.
Misra JS; Singh U
Diagn Cytopathol; 2006 Mar; 34(3):184-7. PubMed ID: 16470854
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of quality assurance in an organized cervical screening program.
Andrae B; Smith P
Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
13. [Cancer in Madagascar. Experience of the Institut Pasteur de Madagascar from September 1992 to June 1996].
Raharisolo Vololonantenaina C; Pécarrère JL; Roux JF
Bull Soc Pathol Exot; 1998; 91(1):17-21. PubMed ID: 9559150
[TBL] [Abstract][Full Text] [Related]
14. [Precancerous lesions of the uterine cervix in Pointe-Noire, Congo].
Moukassa D; N'Golet A; Lingouala LG; Eouani ML; Samba JB; Mambou JV; Ompaligoli S; Moukengue LF; Taty-Pambou E
Med Trop (Mars); 2007 Feb; 67(1):57-60. PubMed ID: 17506275
[TBL] [Abstract][Full Text] [Related]
15. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
17. [Gynaecological and breast cancers at the Dakar Cancer Institute].
Dem A; Traoré B; Dieng MM; Diop PS; Ouajdi T; Lalami MT; Diop M; Dangou JM; Touré P
Sante; 2008; 18(1):25-9. PubMed ID: 18684687
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
20. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
